Prognosis-determinant candidate genes identified by whole genome scanning in eyes with pterygia

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 8, 2007, Pages 3566-3575

  Kuo, Chuan Hui ^a   Miyazaki, Dai ^a   Nawata, Nobuhiko ^a   Tominaga, Takeshi ^a   Yamasaki, Atsushi ^a   Sasaki, Yuji ^a   Inoue, Yoshitsugu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHOSPHOSERINE PHOSPHATASE; SERINE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTOME; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; PHOSPHATASE; PHOSPHOSERINE PHOSPHATASE; POSTN PROTEIN, HUMAN;

ACCURACY; ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CLINICAL ARTICLE; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENOME; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PTERYGIUM; RECURRENT DISEASE; SUPPORT VECTOR MACHINE; UNINDEXED SEQUENCE; ALGORITHM; DNA MICROARRAY; GENETIC MARKER; GENETICS; GENOMICS; MIDDLE AGED; PREDICTION AND FORECASTING;

AGED; ALGORITHMS; CELL ADHESION MOLECULES; CLUSTER ANALYSIS; FEMALE; GENETIC MARKERS; GENOME, HUMAN; GENOMICS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORIC MONOESTER HYDROLASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PTERYGIUM; RECURRENCE; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 34648823263     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1149     Document Type: Article

References (33)

1. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004;23:195-228.
2. Kuo CH, Miyazaki D, Nawata N, Inoue Y. Gene expression profiles in primary and recurrent pterygia. World Cornea Congress V 2005.
3. Solomon A, Grueterich M, Li DQ, Meller D. Lee SB, Tseng SC. Overexpression of Insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci. 2003;44:573-580.
4. Nolan TM, DiGirolamo N, Sachdev NH, Hampartzoumian T, Coroneo MT, Wakefield D. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol. 2003;162:567-574.
5. Tan DT, Liu YP, Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci. 2000;41:1684-1686.
6. Brown MP, Grundy WN, Lin D, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA. 2000;97:262-267.
7. Weinstein JN, Myers TG, O'Connor PM, et al. An information-intensive approach to the molecular pharmacology of cancer. Science. 1997;275:343-349.
8. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-14868.
9. Vapnik VN. The Nature of Statistical Learning Theory. New York: Springer; 1995:188.
10. Kawamoto T, Shimizu M. A method for preparing 2- to 50-micronthick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol. 2000;113:331-339.
11. Kawamoto T. Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch Histol Cytol. 2003;66:123-143.
12. Chen JK, Tsai RJ, Lin SS. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol Anim. 1994;30A:243-248.
13. Detorakis ET, Sourvinos G, Tsamparlakis J, Spandidos DA. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol. 1998;82:1324-1328.
14. Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239-1249.
15. Ulstrup JC, Jeansson S, Wiker HG, Harboe M. Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination. Infect Immun. 1995;63:672-675.
16. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294:271-278.
17. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358-5364.
18. Bao S, Ouyang G, Bai X, et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004;5:329-339.
19. Dake Y, Mukae R, Soda Y, Kaneko M, Amemiya T. Immunohistochemical localization of collagen types I, II, III, and IV in pterygium tissues. Acta Histochem. 1989;87:71-74.
20. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387-2392.
21. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci. 2003;44:4705-4714.
22. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671-679.
23. Solomon A, Li DQ, Lee SB, Tseng SC. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2000;41:2154-2163.
24. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci. 2000;41:4142-4149.
25. Li DQ, Lee SB, Gunja-Smith Z, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol. 2001;119:71-80.
26. Hammani K, Blakis A, Morsette D, et al. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J Biol Chem. 1996;271:25498-25505.
27. Butler GS, Butler MJ, Atkinson SJ, et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A: a kinetic study. J Biol Chem. 1998;273:871-880.
28. Seo DW, Li H, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114:171-180.
29. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115:3719-3727.
30. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 2002;21:2245-2252.
31. Wood PL, Hawkinson JE, Goodnough DB. Formation of D-serine from L-phosphoserine in brain synaptosomes. J Neurochem. 1996;67:1485-1490.
32. Greengard O, Head JF, Chahinian AP, Goldberg SL. Enzyme pathology of human mesotheliomas. J Natl Cancer Inst. 1987;78:617-622.
33. Strunck E, Frank K, Tan MI, Vollmer G. Expression of 1-3-phosphoserine phosphatase is regulated by reconstituted basement membrane. Biochem Biophys Res Commun. 2001;281:747-753.